XERIS PHARMACEUTICALS INC's ticker is XERS and the CUSIP is 98422L107. A total of 69 filers reported holding XERIS PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 1.01 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $2,739,000 | -63.0% | 1,118 | -38.5% | 0.00% | – |
| Q2 2021 | $7,399,000 | -72.7% | 1,818 | -69.7% | 0.00% | – |
| Q1 2021 | $27,060,000 | -39.9% | 6,000 | -34.4% | 0.00% | – |
| Q4 2020 | $45,018,000 | -31.5% | 9,150 | -17.5% | 0.00% | – |
| Q3 2020 | $65,734,000 | +750.9% | 11,085 | +281.7% | 0.00% | – |
| Q2 2020 | $7,725,000 | -57.1% | 2,904 | -68.6% | 0.00% | – |
| Q1 2020 | $18,006,000 | -16.9% | 9,234 | +200.6% | 0.00% | – |
| Q4 2019 | $21,658,000 | -38.0% | 3,072 | -13.6% | 0.00% | – |
| Q3 2019 | $34,946,000 | +32.1% | 3,555 | +53.7% | 0.00% | – |
| Q2 2019 | $26,461,000 | -38.5% | 2,313 | -46.0% | 0.00% | – |
| Q1 2019 | $43,041,000 | – | 4,287 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sessa Capital IM, L.P. | 3,661,237 | $8,970,000 | 0.44% |
| Alpine Global Management, LLC | 370,000 | $907,000 | 0.21% |
| DELTEC ASSET MANAGEMENT LLC | 460,500 | $1,128,000 | 0.17% |
| IHT Wealth Management, LLC | 334,367 | $819,000 | 0.07% |
| Redmile Group, LLC | 1,358,825 | $3,329,000 | 0.06% |
| GPS Wealth Strategies Group, LLC | 58,025 | $142,000 | 0.04% |
| Granahan Investment Management | 465,049 | $1,139,000 | 0.02% |
| SEARLE & CO. | 20,000 | $49,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 402,300 | $986,000 | 0.02% |
| Gladstone Institutional Advisory LLC | 53,500 | $131 | 0.01% |